[{"Assets_0_Q1_USD":6543114000.0,"CIK":"875320","CommonStockSharesConverted_0_Q1_shares":256351000.0,"CommonStockSharesOutstanding_0_Q1_shares":256351000.0,"Country":"United States","EarningsPerShareBasic_1_Q1_USD":1.05,"EarningsPerShareDiluted_1_Q1_USD":1.03,"Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","Market Cap":"72193451271.0","NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":324784000.0,"NetIncomeLossConverted_1_Q1_USD":268631000.0,"OfficialName":"Vertex Pharmaceuticals Incorporated Common Stock","RevenuesConverted_1_Q1_USD":858435000.0,"SP500":"SP500","Sector":"Health Care","StockholdersEquityConverted_0_Q1_USD":4723313000.0,"Ticker":"VRTX","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":260175000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":255695000.0,"filed":"20190501","footnote":"nan","form":"10-Q","fp":"Q1","fy":"2019.0","name":"VERTEX PHARMACEUTICALS INC \/ MA","period":"20190331","qtrs":"0","uom":"USD"}]